Quantum BioPharma Ltd. is trading 6% up at $4.06 in pre-market, rebounding from recent multi-day weakness and a 4.3% slide on Friday.
- The upward move aligns with a strong risk-on tone in U.S. equity futures following a U.S.–Iran peace breakthrough and lower oil prices.
- Growth and biotech sectors are broadly higher as macro sentiment improves, despite a lack of fresh company-specific headlines.
- Shares are attempting to recover ground lost during a technical-driven selloff that began on June 12.